SEC Form 4
Palisade Bio, Inc. (PALI) insider trading
In the 12 months to Oct 26, 2026, 2 PALI insiders reported open-market purchases of $296.7K across 6 filings; no open-market sales were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $0
- 0 filings · 0 insiders
- Open-market purchases
- $296.7K
- 6 filings
Who traded PALI, and when
- Purchase
PALI daily close from Oct 27, 2025 to Oct 26, 2026, between $1.27 and $2.80, last $1.27. 0 sale and 6 purchase filings by 2 insiders, marked at their filing dates. Robert Baltera JR., Director: bought $250.2K across 3 filings, first filed Jul 6, 2026, last Jul 10, 2026. Donald Allen Williams, Director: bought $46.6K across 3 filings, first filed Jan 13, 2026, last Oct 5, 2026.
Largest mark · tap a row for others
Robert Baltera JR. · Director
Filing 1 of 3 within a week · $250,182 total
Purchase $59,400
30,000 shares at $1.98 avg
Filed Jul 6, 2026 · traded Jul 1
Close on filing date $2.04
Robert Baltera JR. · Director
Director
$250.2K boughtDonald Allen Williams · Director
Director
$46.6K boughtOpen-market trades
6 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Robert Baltera JR. | Director | — | $250.2K | 3 | — | |
| Donald Allen Williams | Director | — | $46.6K | 3 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Donald Allen Williams Director | Purchase | 20,000 | $1.44 | $28.8K | 1,590,294 | |
traded | Robert Baltera JR. Director | Purchase | 45,000 | $1.97 | $88.7K | 461,904 | |
traded | Robert Baltera JR. Director | Purchase | 50,000 | $2.04 | $102.1K | 416,904 | |
traded | Robert Baltera JR. Director | Purchase | 30,000 | $1.98 | $59.4K | 366,904 | |
traded | Donald Allen Williams Director | Purchase | 5,000 | $1.67 | $8.4K | 10,728 | |
traded | Donald Allen Williams Director | Purchase | 5,000 | $1.88 | $9.4K | 5,728 |
GET /stocks/filings/vX/form-4?tickers=PALI&filing_date.gte=2025-10-26&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"PALI"
],
"issuer_cik": "0001357459",
"owner_cik": "0001620013",
"accession_number": "0001493152-26-045772",
"form_type": "4",
"filing_date": "2026-10-05",
"period_of_report": "2026-10-01",
"issuer_name": "PALISADE BIO, INC.",
"issuer_trading_symbol": "PALI",
"owner_name": "Williams Donald Allen",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": false,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-10-01",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 10000,
"transaction_price_per_share": 1.42,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 1580294,
"transaction_value": 14200,
"not_subject_to_section_16": false,
"direct_or_indirect": "D"
},
{
"tickers": [
"PALI"
],
"issuer_cik": "0001357459",
"owner_cik": "0001620013",
"accession_number": "0001493152-26-045772",
"form_type": "4",
"filing_date": "2026-10-05",
"period_of_report": "2026-10-01",
"issuer_name": "PALISADE BIO, INC.",
"issuer_trading_symbol": "PALI",
"owner_name": "Williams Donald Allen",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": false,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-10-02",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 10000,
"transaction_price_per_share": 1.46,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 1590294,
"transaction_value": 14600,
"not_subject_to_section_16": false,
"direct_or_indirect": "D"
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 24 records
- Option exercises10 records
- Tax withholding2 records
- Tax withholding (sold to cover)4 records
- Grants and awards6 records
- Gifts2 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Frequently asked questions
Has Palisade Bio, Inc.'s CEO sold stock?
No. John David Finley (CEO) made no open-market sales filed as CEO in the last 12 months.
How current is PALI’s insider data?
These are PALI Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track PALI insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for PALI every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.